(Q36324051)

13 August 2017

Disease Burden from Hepatitis B Virus Infection in Guangdong Province, China (English)

1 reference

13 August 2017

1 reference

Jianpeng Xiao

1

1 reference

13 August 2017

Hualiang Lin

2

1 reference

13 August 2017

Tao Liu

3

1 reference

13 August 2017

Weilin Zeng

4

1 reference

13 August 2017

Xing Li

5

1 reference

13 August 2017

Xiaoping Shao

6

1 reference

13 August 2017

Qiu Tan

7

1 reference

13 August 2017

Yanjun Xu

8

1 reference

13 August 2017

Xiaojun Xu

9

1 reference

13 August 2017

Huizhen Zheng

10

1 reference

13 August 2017

Wenjun Ma

11

1 reference

13 August 2017

2 November 2015

1 reference

International Journal of Environmental Research and Public Health

13 August 2017

1 reference

13 August 2017

12

1 reference

13 August 2017

11

1 reference

13 August 2017

14055-14067

1 reference

Creative Commons Attribution 4.0 International

13 August 2017

start time

2 November 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661632

Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661632

The global burden of liver disease: the major impact of China

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661632

The economic burden of opioid-related poisoning in the United States

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661632

Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661632

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661632

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661632

Impact of hepatitis B vaccination among children in Guangdong Province, China

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661632

Assessment of total economic burden of chronic hepatitis B (CHB)-related diseases in Beijing and Guangzhou, China

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661632

Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661632

Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661632

The societal burden of HBV-related disease: South Korea

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661632

Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661632

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661632

Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661632

A thirty-one year prospective follow-up program on the HBsAg carrier state and primary liver cancer in Qidong, China

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661632

How big is the financial burden of hepatitis B to society? A cost-of-illness study of hepatitis B infection in Singapore.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661632

[Estimation on the intangible cost and influencing factors for patients with hepatitis B-related diseases].

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661632

Etiologic fraction and interaction of risk factors for primary hepatic carcinoma in Guangxi, China

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661632

A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661632

Long-term morbidity and mortality in Chinese insurance applicants infected with the hepatitis B virus.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661632

Hepatitis B virus infection

22 September 2018

1 reference

PubMed

12 December 2020

[Estimation on disease burden related to hepatitis B virus infection in Shandong province of China]

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

Hepatitis B virus infection

1 reference

PubMed

12 December 2020

Identifiers

DOI

10.3390/IJERPH121114055

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

26540065

1 reference